(Q54495025)

30 May 2018

title

EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas. (English)

1 reference

30 May 2018

author

Hiroshi Minato

3

1 reference

30 May 2018

author name string

Shioto Suzuki

1

1 reference

30 May 2018

Yoh Dobashi

2

1 reference

30 May 2018

Ryosuke Tajiri

4

1 reference

30 May 2018

Tomokazu Yoshizaki

5

1 reference

30 May 2018

Akishi Ooi

6

1 reference

30 May 2018

publication date

25 July 2012

1 reference

30 May 2018

published in

Virchows Archiv

1 reference

30 May 2018

volume

461

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

271-282

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s00428-012-1282-3

exact match

0 references

cites work

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

HER2 expression in salivary gland carcinomas: dependence on histological subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Diversity of epidermal growth factor receptor-mediated activation of downstream molecules in human lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

HER2 testing in the UK: further update to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Effects of HER2 overexpression on cell signaling networks governing proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

The role of the epidermal growth factor receptor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1282-3

Mammalian target of rapamycin: a central node of complex signaling cascades

21 January 2018

1 reference

12 December 2020

MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma

1 reference

12 December 2020

The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

1 reference

12 December 2020

Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin

1 reference

12 December 2020

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis

1 reference

12 December 2020

Parotid carcinoma: expression of kit protein and epidermal growth factor receptor

1 reference

12 December 2020

10.1007/S00428-012-1282-3

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dnqw5rlrwzcwxhashz2ksguusi

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_dnqw5rlrwzcwxhashz2ksguusi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dnqw5rlrwzcwxhashz2ksguusi

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/dnqw5rlrwzcwxhashz2ksguusi

1 reference

30 July 2022